These findings could have significant implications for further research into the mechanisms underlying diabetes and obesity, as well as potential therapeutic interventions aimed at modulating GDF-15 levels to mitigate metabolic risks. This evidence concerns the gene GDF15 and obesity due to melanocortin 4 receptor deficiency.